India’s AAP to expand network in Gulf countries

India’s AAP to expand network in Gulf countries
Updated 28 February 2016

India’s AAP to expand network in Gulf countries

India’s AAP to expand network in Gulf countries

RIYADH: Indians here held a function to observe Aam Aadmi Party’s (AAP) completion of one year in office in Riyadh.
The event marked AAP’s historic decision to expand its network globally including in the Gulf countries, where nearly seven million Indian expats are currently working.
Speaking on the occasion, a legislator of Delhi’s ruling party and the party’s co-convener of its Overseas Chapter, Adarsh Shastri, said the party provides an alternative system of good governance.
“India’s deep rooted corruption and dynastic political system will be transformed to non-corrupt, development- and issue-based governance by AAP,” he said and hailed Arvind Kejriwal’s leadership.
The event, attended by a large number of expatriates, also provided an opportunity to take stock of the situation of India, which has been marred by several controversies and movements in recent times.
Shastri said the mood of the country toward the political system has changed after path-breaking initiatives taken by the AAP government after it came to power in Delhi in early 2014.
Social infrastructure like education, health, social welfare have been given top priority while free water, electricity, abolition of VIP status, completion of public projects were ensured to be completed within stipulated time.
Besides, citizens participation in administration through mohalla sabha, passing the janalokpaal bill, taking strict action against corrupt officials have restored people’s confidence in government and party, he said.
Kerala State Convener C. R. Neelakandan also spoke on the occasion, which was presided over by Basheer Aramboor. Mansoor welcomed the audience while Abdul Azees proposed the vote of thanks. Shameem conducted the program.
During the interactive session that followed, a number of questions about AAP including poor attention given to senior citizens in government hospitals, poor health infrastructure, corruption, unauthorized constructions, adulteration in food items, turning Yamuna shores into spots for tourist attraction, participation of public in decision-making process and other issues were discussed. AAP has developed a strong support base in India as well as among the Indian expatriates community across the globe. Party supporters and well-wishers from the different parts of the country participated in the event.


Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
Updated 16 January 2021

Saudi Arabia’s first COVID-19 vaccine set for clinical trials

Saudi Arabia’s first COVID-19 vaccine set for clinical trials
  • It will go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority

RIYADH: Preclinical studies on the first Saudi vaccine against COVID-19 have been completed.

Professor of epidemiology Dr. Iman Almansour, who heads the team of researchers working on the vaccine at the Institute for Research and Medical Consultations (IRMC), affiliated with Imam Abdulrahman Bin Faisal University (IAU), confirmed to Arab News on Friday that the studies were complete, and said clinical trials would begin as soon as “the proper approvals” had been given.

She did not specify when that is expected to happen.

The Ministry of Education is financing the team’s project. The team’s research paper has been published in the peer-reviewed journal Pharmaceuticals.

The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen.

Dr. Iman Almansour, professor of epidemiology

According to the published paper, the vaccine has so far proven effective, when used on animals, in eliciting antibodies that will target the virus. “The vaccine is given to the body to build protein inside cells, which stimulate the body to produce immunity specific to the S antigen,” Dr. Almansour explained.

Dr. Turki Almugaiteeb, director of Healthcare and Life Sciences at RPD Innovations, which runs the National Vaccine and Biomanufacturing Center, told Arab News: “There is a great focus on the results of medical research because of the pandemic. Research can play a great role in developing a vaccine that can be adopted and further developed in the future. We can say that the Kingdom has a strong infrastructure, which can help produce and manufacture a national vaccine.”

Both Almugaiteeb and Almansour stressed that the experimental vaccine will need to go through rigorous testing and several trial stages before it is approved for use by the Saudi Food and Drug Authority.

Prof. Nasser Al-Aqeeli, the deputy minister of education for research and innovation, said the ministry supported programs at the Kingdom’s universities with more than SR500 million ($133.3 million) in 2020.